Mistaking units for milligrams or doubling up after a missed week can turn a routine weight loss injection into a medical ...

Influencers, content creators and celebrities across social media platforms are touting the benefits of GLP-1 drugs, but many of them aren’t taking them in the same dosages as most weight loss ...

As GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) continue to help manage metabolic disorders and obesity, a new trend is rapidly gaining traction on ...

GLP-1s are proving to be one of the most important medical advances of our time. According to data collected from the Centers for Disease Control and Prevention, 32.4% of people in the U.S. with ...

Are your patients taking their GLP-1s as prescribed? Some patients on GLP-1s appear to be taking liberties with their dosing schedules, according to published case data and anecdotal evidence. Current ...

The WHO issued new guidelines endorsing GLP-1 receptor agonists for the long-term treatment of obesity in adults. GLP-1 drugs must be combined with counseling on behavioral and lifestyle changes, the ...

Columbus, OH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity. The agency said the weight-loss drugs should be used in conjunction with a healthy ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented detailed results from multiple Phase 2b studies of berobenatide (PF’3944), an investigational, potential first-in-class monthly GLP-1 ...

The surge in injectable weight loss medications like Ozempic and Wegovy has coincided with a troubling uptick of GLP-1 overdoses. While many cases have been mild, poison control centers have seen a ...